Skip to main content

Christopher Bull Granger

Donald F. Fortin, M.D. Distinguished Professor of Medicine
Medicine, Cardiology
Duke Box 3409, Durham, NC 27710
300 West Morgan Street, Durham, NC 27701

Selected Grants


Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2028

CCC: The Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 1/2

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2027

Integrated Biostatistical Training for CVD Research

Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027

RECOVER Auto Dysfunction Protocol

Clinical TrialPrincipal Investigator · Awarded by Research Triangle Institute International · 2022 - 2026

A Controlled trial to improve use of High IntEnsity statins for Vascular protEction: ACHIEVE

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2028

CCC: The Regional Approaches to Cardiovascular Emergencies- Cardiac ARreSt (RACE-CARS) Cluster-Randomized Trial 1/2

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2027

Integrated Biostatistical Training for CVD Research

Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027

RECOVER Auto Dysfunction Protocol

Clinical TrialPrincipal Investigator · Awarded by Research Triangle Institute International · 2022 - 2026

A Controlled trial to improve use of High IntEnsity statins for Vascular protEction: ACHIEVE

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2025

Shingrix

ResearchPrincipal Investigator · Awarded by Harvard Pilgrim Health Care, Inc. · 2023 - 2025

Implementation Summit

ConferencePrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2023 - 2024

COORDINATE Diabetes Study

ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2018 - 2024

COORDINATE Diabetes Website

Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2023 - 2024

Implementation Summit

ConferencePrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2023 - 2024

Implementation Summit

ConferencePrincipal Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2023 - 2024

Printed Electronic Biosensors for Point-of-Care Testing of Cardiovascular Biomarkers

ResearchCollaborator · Awarded by National Institutes of Health · 2019 - 2024

Postdoctoral Training in Cardiovascular Clinical Research

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2024

PARADISE

ResearchPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2017 - 2022

HeartRescue

ResearchPrincipal Investigator · Awarded by University of Washington · 2016 - 2021

Effect of monitoring system design on response time to cardiac arrhythmias

ResearchCo Investigator · Awarded by Agency for Healthcare Research and Quality · 2015 - 2021

Prehospital Termination of Resuscitation in Out-of-Hospital Cardiac Arrest

ResearchCollaborating Investigator · Awarded by Society for Academic Emergency Medicine · 2019 - 2020

Evaluating and Improving Cardiac Arrest Resuscitation Efforts in Hemodialysis Clinics

ResearchSignificant Contributor · Awarded by National Institutes of Health · 2017 - 2020

Janssen AF Quality Improvement Research Study

ResearchPrincipal Investigator · Awarded by Janssen Pharmaceutica, Inc. · 2017 - 2019

Implementation of Demonstration Project for Health Systems: Atrial Fibrillation(INFORM-AF)

ResearchPrincipal Investigator · Awarded by Janssen Scientific Affairs, LLC. · 2016 - 2019

Regional Systems Accelerator: Implementation of the AHA Mission (TMC)

ResearchPrincipal Investigator · Awarded by The Medicines Company · 2016 - 2017

Heart Rescue Flagship Premier Partner Program "RACE CARs"

ResearchPrincipal Investigator · Awarded by Medtronic Foundation · 2013 - 2017

HeartRescue

ResearchPrincipal Investigator · Awarded by University of Washington · 2016 - 2017

Workload effects on response time to life-threatening arrhythmias

ResearchInvestigator · Awarded by Agency for Healthcare Research and Quality · 2012 - 2014

Rare Thrombotic Diseases Clinical Research Network

ResearchCollaborator · Awarded by National Institutes of Health · 2004 - 2010

GENECARD: Gene identification in Early-Onset CAD

ResearchCo Investigator · Awarded by National Institutes of Health · 2003 - 2009

DCRI CERT for Cardiovascular Therapies

ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 2002

External Relationships


  • Abiomed, Inc. (now acquired by Johnson & Johnson)
  • Alnylam Pharmaceutical, Inc.
  • Anthos
  • Bayer Healthcare Pharmaceuticals, Germany
  • Boehringer Ingelheim/Lilly alliance
  • Abiomed, Inc. (now acquired by Johnson & Johnson)
  • Alnylam Pharmaceutical, Inc.
  • Anthos
  • Bayer Healthcare Pharmaceuticals, Germany
  • Boehringer Ingelheim/Lilly alliance
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Cardionomic
  • Celecor
  • FDA
  • Janssen Pharmaceuticals
  • Medtronic
  • Merck
  • Nephrosynergy
  • Novartis pharmaceuticals
  • Novo Nordisk
  • Pfizer Inc.
  • Phillips
  • Reata Pharmaceuticals, Inc.
  • tenacio

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.